Growing Demand and Advancements in Treatment: Primary Sclerosing Cholangitis (PSC) Market Expands with Promise of Improved Patient Outcomes

  The emergence of targeted therapies and precision medicine approaches holds immense promise for PSC patients. Researchers and pharmaceutical companies are actively investigating novel therapeutic modalities that aim to halt or slow disease progression, alleviate symptoms, and prevent complications. Additionally, advancements in liver transplantation techniques, including living-donor liver transplantation and alternative graft sources, provide new […]